Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 4, 2025Pakistan Journal of Pharmaceutical Sciences

Comparison Of Inflammatory Control And Safety By Timing Of Doxycycline-Azithromycin Dual Therapy In Pediatric Mycoplasmal Pneumonia

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Comparison of timing effects on clinical efficacy and safety in pediatric mycoplasmal pneumonia shows shorter symptom duration with doxycycline therapy within 72 hours, indicating dual therapy benefit

Key Points

  • Shorter symptom improvement time observed in the group receiving doxycycline within 72 hours after azithromycin administration.
  • Both treatment groups showed no significant differences in clinical efficacy or pulmonary function results (P>0.05).
  • Long-term doxycycline use increased safety by decreasing inflammatory and stress responses, alongside lower complication rates (P<0.05).
  • Study highlights the importance of timing in antibiotic therapy for effective inflammatory control in pediatric mycoplasmal pneumonia.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/690945348f2297dc135330adhttps://doi.org/10.36721/pjps.2025.38.6.reg.14009.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods2024 · 27 citations
  2. 2Association of doxycycline treatment with time to first documented MP-RNA negative conversion in pediatric Mycoplasma pneumoniae pneumonia: a retrospective cohort study2026
  3. 3Doxycycline for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children: Analysis of Efficacy and Safety Across Different Age Groups2025
  4. 4Comparison of Clinical Outcomes and Fever Clearance Time with Azithromycin versus Doxycycline in Paediatrics Scrub Typhus2026
  5. 5Comparative observation between Roxithromycin and Azithromycin sequential therapy in the treatment of Mycoplasma pneumoniae Pneumonia in Children2024